SV The New Vaccines

Proportions.JPG (67009 bytes)Scientia Veritas, L.L.P.


 


About Us        Healthcare        Toxicology        Contact Us        Search         ScientiaVision Reports

         
NEW! ScientiaVision Product Pinpoint: The New Vaccines        NEW! ScientiaVision Competitor Close-Up: Merck

Retrieve Order

About Us

Toxicology

Healthcare

ScientiaVision Reports

Updates: Vaccines

TOC-LOEs

Coming Soon

Search

Advanced Search

Contact Us

 

Gain the Competitive Advantage with The New Vaccines

  • Global and regional sales and forecasts, with market sizes and trends for the U.S., Europe, Japan, China, India, and the Rest of the World, 2005-2013.

  • Sales, market shares, forecasts, and trends for each of seven vaccine categories:  Cancer, Hepatitis, Influenza, Meningococcus and Pneumococcus, Rotavirus, Travel and Endemic, and Other.  Market shares for 2005-2008, sales and forecasts for 2005-2013.

  • Worldwide and regional immunization rates.

  • R&D activities around the world.

  • Competitor analyses.

  • Opportunities for growth.

  • Fresh perspective on the vaccines market.

  • Easy to use data, tables, and graphs, with all information presented in both U.S. dollars and Euros.

  • Find it fast with the convenient, bookmarked .pdf file.

The New Vaccines provides sales, market shares, trends, strategies, opportunities, pitfalls, and analyses of key competitors to help you profit in the vaccines market.


Achieve Success in the Global Vaccines Market with
Product Pinpoint: The New Vaccines.


Click here to download free Table of Contents and List of Exhibits

See what we have to offer.  Download the Executive Summary FREE

See our Vaccine Updates

 


SV103Vaccines
ScientiaVision Product Pinpoint: The New Vaccines
Published March 2009

ScientiaVision Product Pinpoint: The New Vaccines focuses on growth, opportunity, challenges, products, and competitors in the worldwide vaccine market. The industry has grown from primarily comprising commodity vaccines to a market that includes several blockbuster products, encompasses myriad licensing agreements with biotechnology companies, and is expanding through the creation of entirely new market segments. 

The worldwide market for vaccines has more than doubled in three years, from US$11.6 billion (€9.4 billion) in 2005 to US$25.2 billion (€16.5 billion) in 2008, having grown at a compound annual rate of 31.8% (27.6% for Euros).  The market has primarily been driven by the billion-dollar products Prevnar (Wyeth); Gardasil (Merck); Merck’s ProQuad/M-M-R II/Varivax line; GlaxoSmithKline’s Infanrx and Pediarix; GlaxoSmithKline’s hepatitis line; Sanofi Pasteur’s line of polio/whooping cough/Hib vaccines; and Sanofi Pasteur’s line of influenza vaccines.  For the forecast period, SV projects that sales will more than double again to US$50.7 billion (€34.7 billion) in 2013, reflecting compound annual growth of 21.7% (19.2% for Euros). 

This report breaks the market down by regions, as well as by product categories, with historical (2005 to 2007), base year (2008), and forecast data (2009 to 2013) for each market segment.  Market shares are provided for 2005 through 2008. All sales and market estimates are presented both in U.S. Dollars and Euros.  215 pages, 75 exhibits.

Price: $2,995.00

Format
File download

Quantity:


Email a Friend


ScientiaVision reports are sold at the following websites:

 


Secure transactions provided by CardService International.

 

Home | Search | Current Order | Saved Cart

 


Scientia Veritas, L.L.P.
5910 Northwood Drive
Evergreen, CO  80439
www.ScientiaVeritas.com
Healthcare:  (303) 674-3732;  Healthcare@ScientiaVeritas.com
Toxicology/Risk Assessment:  (303) 674-8751;  Toxicology@ScientiaVeritas.com
Fax:  (303) 674-8755